Abstract
IntroductionAccurate prediction of patients at risk for early recurrence (ER) among patients with colorectal liver metastases (CRLM) following preoperative chemotherapy and hepatectomy remains limited. MethodsPatients with CRLM who received chemotherapy prior to undergoing curative-intent resection between 2000 and 2020 were identified from an international multi-institutional database. Multivariable Cox regression analysis was used to assess clinicopathological factors associated with ER, and an online calculator was developed and validated. ResultsAmong 768 patients undergoing preoperative chemotherapy and curative-intent resection, 128 (16.7 %) patients had ER. Multivariable Cox analysis demonstrated that Eastern Cooperative Oncology Group Performance status ≥1 (HR 2.09, 95%CI 1.46–2.98), rectal cancer (HR 1.95, 95%CI 1.35–2.83), lymph node metastases (HR 2.39, 95%CI 1.60–3.56), mutated Kirsten rat sarcoma oncogene status (HR 1.95, 95%CI 1.25–3.02), increase in tumor burden score during chemotherapy (HR 1.51, 95%CI 1.03–2.24), and bilateral metastases (HR 1.94, 95%CI 1.35–2.79) were independent predictors of ER in the preoperative setting. In the postoperative model, in addition to the aforementioned factors, tumor regression grade was associated with higher hazards of ER (HR 1.91, 95%CI 1.32–2.75), while receipt of adjuvant chemotherapy was associated with lower likelihood of ER (HR 0.44, 95%CI 0.30–0.63). The discriminative accuracy of the preoperative (training: c-index: 0.77, 95%CI 0.72–0.81; internal validation: c-index: 0.79, 95%CI 0.75–0.82) and postoperative (training: c-index: 0.79, 95%CI 0.75–0.83; internal validation: c-index: 0.81, 95%CI 0.77–0.84) models was favorable (https://junkawashima.shinyapps.io/CRLMfollwingchemotherapy/). ConclusionsPatient-, tumor- and treatment-related characteristics in the preoperative and postoperative setting were utilized to develop an online, easy-to-use risk calculator for ER following resection of CRLM.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callSimilar Papers
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
